Invention Grant
- Patent Title: CCR3 inhibition for ocular angiogenesis and macular degeneration
- Patent Title (中): CCR3抑制眼血管发生和黄斑变性
-
Application No.: US13177986Application Date: 2011-07-07
-
Publication No.: US08592482B2Publication Date: 2013-11-26
- Inventor: Jayakrishna Ambati
- Applicant: Jayakrishna Ambati
- Applicant Address: US KY Lexington
- Assignee: University of Kentucky Research Foundation
- Current Assignee: University of Kentucky Research Foundation
- Current Assignee Address: US KY Lexington
- Agency: Crowell & Moring LLP
- Main IPC: A01N37/44
- IPC: A01N37/44 ; A61K31/195
Abstract:
Provided are methods and compositions for the treatment or prevention of ocular angiogenesis and neovascularization. Administration of inhibitors of the CCR3 receptor or its ligands eotaxin (CCL11), eotaxin-2 (CCL24) or eotaxin-3 (CCL26) inhibits ocular angiogenesis.
Public/Granted literature
- US20110268723A1 CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration Public/Granted day:2011-11-03
Information query
IPC分类:
